TwoStep Therapeutics on LinkedIn: We’re excited to announce our official launch and the closing of a $6.5M…
Summary
Were excited to announce our official launch and the closing of a $6.5M seed round to advance our pipeline of targeted therapies for solid tumors. Our delivery platform is built around a unique tumor-targeting agent that can selectively bind five targets that are highly expressed on solid tumors. This multi-targeting feature enables broad applicability across a wide range of tumor types and patient populations, overcoming the limitations of traditional single-antigen targeting approaches. Led by co-founder and CEO Caitlyn Miller, PhD, our mission is to revolutionize cancer care by developing precise, effective, and broadly applicable targeted therapies. Our work is guided by world-class academic-entrepreneurs at Stanford, including co-founders Carolyn Bertozzi, Jennifer Cochran and Ron Levy.